John E. Reardon - Concepedia

Author

John E. Reardon

Also Known As

J E Reardon, J Reardon, J. E. REARDON, J. E. Reardon, J. Reardon, J.E. Reardon, John E Reardon, John E. Reardon, John E. Reardon Jr., John Edward Reardon

103

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation Burroughs Wellcome Fund HemoShear (United States)

About

John E. Reardon is an author at Research Triangle Park Foundation specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.9K
2	Natural Sciences	16	17	1.5K
3	Biochemistry	15	16	1.5K
4	Biomolecular Engineering	6	6	392
5	Engineering	3	3	285

John E. Reardon

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity Susan M. Daluge, Steven S. Good, M B Faletto, Antimicrobial Agents and Chemotherapy ImmunologyPharmacotherapyAntiviral DrugPharmaceutical ChemistryMolecular Pharmacology	1997	384
Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis J L Martin, Claire Brown, N Matthews-Davis, Antimicrobial Agents and Chemotherapy Molecular BiologyAntiviral DrugDna PolymerasesAntiviral Nucleoside AnalogsNucleic Acid Chemistry	1994	341
New reactants for the colorimetric determination of ammonia John E. Reardon, J.A. Foreman, R.L. Searcy Clinica Chimica Acta EngineeringColorimetryOrganic ChemistryAnalytical ChemistryAmmonia	1966	245
Herpes simplex virus type 1 DNA polymerase John E. Reardon, T Spector Journal of Biological Chemistry	1989	208
Reverse transcriptase.RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. Eric S. Furfine, John E. Reardon Journal of Biological Chemistry	1991	179
Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir Sylvia C. Stanat, John E. Reardon, Alejo Erice, Antimicrobial Agents and Chemotherapy MedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirology	1991	170
Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation John E. Reardon Biochemistry Pre-steady-state KineticsViral ReplicationBioorganic ChemistryDissociation ConstantMolecular Biology	1992	144
Management of oxaliplatin-induced peripheral neuropathy. Muhammad Wasif Saif, John E. Reardon PubMed Peripheral Nerve InjuryPain MedicineOxaliplatin-induced Peripheral NeuropathyNeuropathic PainPharmacotherapy	2005	141
Biochemical studies on the reverse transcriptase and RNase H activities from human immunodeficiency virus strains resistant to 3‘-azido-3‘-deoxythymidine. Simon F. Lacey, John E. Reardon, Eric S. Furfine, Journal of Biological Chemistry	1992	117
Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate John E. Reardon, Wayne H. Miller Journal of Biological Chemistry	1990	112

Page 1